You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Diabetes Articles
Popular Diabetes Articles
Highly Recommended Diabetes Articles
Send a link to this page to your friends and colleagues.
According to a January 5, 2006, posting on its Web site (www.fda.gov), GlaxoSmithKline and the FDA have notified healthcare professionals about post-marketing reports of new-onset and worsening diabetic macular edema for patients receiving Avandia.
“In the majority of these cases, the patients also reported concurrent peripheral edema,” the FDA writes. “In some cases, the macular edema resolved or improved following discontinuation of therapy and in one case, macular edema resolved after dose reduction.”
In a letter to healthcare providers, Alexander R. Cobitz, MD, PhD, of GlaxoSmithKline announced that the company would be highlighting this precaution in all Avandia, Avandamet and Avandaryl product information for prescribers and patient information leaflets.
What is macular edema?
Macular edema is swelling of the retina in diabetes mellitus due to leaking of fluid from blood vessels within the macula. The macula is the central portion of the retina, a small area rich in cones, the specialized nerve endings that detect color and upon which daytime vision depends.
Jul 1, 2006
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.